DK2344166T3 - Farmaceutisk præparat til behandlingen af gastrointestinale irritationslidelser - Google Patents

Farmaceutisk præparat til behandlingen af gastrointestinale irritationslidelser

Info

Publication number
DK2344166T3
DK2344166T3 DK09736868.2T DK09736868T DK2344166T3 DK 2344166 T3 DK2344166 T3 DK 2344166T3 DK 09736868 T DK09736868 T DK 09736868T DK 2344166 T3 DK2344166 T3 DK 2344166T3
Authority
DK
Denmark
Prior art keywords
diseases
treatment
pharmaceutical preparation
gastrointestinal irritation
irritation
Prior art date
Application number
DK09736868.2T
Other languages
English (en)
Inventor
Salvatore Bellinvia
Laura Martelli
Mario Martelli
Original Assignee
Giuliani Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Giuliani Spa filed Critical Giuliani Spa
Application granted granted Critical
Publication of DK2344166T3 publication Critical patent/DK2344166T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/688—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols both hydroxy compounds having nitrogen atoms, e.g. sphingomyelins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7024—Esters of saccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K33/00—Medicinal preparations containing inorganic active ingredients
    • A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
    • A61K33/08—Oxides; Hydroxides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Inorganic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK09736868.2T 2008-09-17 2009-09-16 Farmaceutisk præparat til behandlingen af gastrointestinale irritationslidelser DK2344166T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP08425607A EP2172203A1 (en) 2008-09-17 2008-09-17 Pharmaceutical composition for the treatment of gastrointestinal irritation disorders
PCT/EP2009/061997 WO2010031785A1 (en) 2008-09-17 2009-09-16 Pharmaceutical composition for the treatment of gastrointestinal irritation disorders

Publications (1)

Publication Number Publication Date
DK2344166T3 true DK2344166T3 (da) 2013-02-25

Family

ID=40279068

Family Applications (1)

Application Number Title Priority Date Filing Date
DK09736868.2T DK2344166T3 (da) 2008-09-17 2009-09-16 Farmaceutisk præparat til behandlingen af gastrointestinale irritationslidelser

Country Status (10)

Country Link
EP (2) EP2172203A1 (da)
CY (1) CY1113724T1 (da)
DK (1) DK2344166T3 (da)
ES (1) ES2400111T3 (da)
HR (1) HRP20130112T1 (da)
PL (1) PL2344166T3 (da)
PT (1) PT2344166E (da)
RU (1) RU2497527C2 (da)
SI (1) SI2344166T1 (da)
WO (1) WO2010031785A1 (da)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITRM20120041A1 (it) 2012-02-08 2013-08-09 Dicofarm Spa "prodotto a base di glucomannano e chitosano utile per il trattamento del reflusso gastroesofageo"
EP3308773A1 (en) 2016-10-11 2018-04-18 Recordati Industria Chimica E Farmaceutica SPA Formulations of cysteamine and cysteamine derivatives
IT202100000059A1 (it) * 2021-01-04 2022-07-04 Nyuma Pharma Srl Nuove composizioni di sucralfato in alginato e loro utilizzo in terapia

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4064234A (en) * 1974-06-04 1977-12-20 Bristol-Myers Company Methods and pharmaceutical preparation for the treatment of hypercholesterolemia
DE3374914D1 (en) * 1982-04-12 1988-01-28 Univ Texas Methods and compositions for treating gastro-intestinal ulcer diesease
US4542019A (en) * 1983-03-11 1985-09-17 John Lezdey Antacid compositions
US4609543A (en) * 1983-11-14 1986-09-02 Nabisco Brands, Inc. Soft homogeneous antacid tablet
GB2195890A (en) * 1986-10-06 1988-04-20 Procter & Gamble Improving palatability of pharmaceutical chewable tablets
US4918063A (en) * 1987-02-17 1990-04-17 Board Of Regents, The University Of Texas System Methods and compositions employing unique mixtures of polar and neutral lipids for protecting the gastrointestinal tract
TW209174B (da) * 1991-04-19 1993-07-11 Takeda Pharm Industry Co Ltd
ATE192932T1 (de) * 1993-09-09 2000-06-15 Takeda Chemical Industries Ltd Formulierung enthaltend einen antibakteriellen und einen antiulcus wirkstoff
US5955451A (en) 1995-05-12 1999-09-21 The University Of Texas System Board Of Regents Methods of enhancing the therapeutic activity of NSAIDS and compositions of zwitterionic phospholipids useful therein
KR20010055274A (ko) * 1999-12-10 2001-07-04 김재수 항피로용 건강 보조식품
US7226916B1 (en) * 2000-05-08 2007-06-05 N.V. Nutricia Preparation for the prevention and/or treatment of vascular disorders
RU2315596C1 (ru) * 2006-09-28 2008-01-27 Александр Владимирович Диковский Фармацевтическая композиция, обладающая антацидным и репаративным действием, получение и применение

Also Published As

Publication number Publication date
EP2344166A1 (en) 2011-07-20
PT2344166E (pt) 2013-03-05
EP2344166B1 (en) 2012-12-05
CY1113724T1 (el) 2016-06-22
WO2010031785A1 (en) 2010-03-25
EP2172203A1 (en) 2010-04-07
RU2011115043A (ru) 2012-10-27
HRP20130112T1 (hr) 2013-03-31
PL2344166T3 (pl) 2013-05-31
SI2344166T1 (sl) 2013-04-30
RU2497527C2 (ru) 2013-11-10
ES2400111T3 (es) 2013-04-05

Similar Documents

Publication Publication Date Title
IL255752B (en) Compounds, pharmaceutical compositions comprising the same and uses thereof for treating cardiovasclar disease, an inflammatory disease or cancer
BRPI1012116A2 (pt) composição farmacêutica para o tratamento de doenças cardíacas
DK2504005T3 (da) Anvendelse af 1,3-diphenylprop-2-en-1-on-derivater til behandling af lever-sygdomme
HUS1600048I1 (hu) Készítmény Fabry-kór kezelésére
DK2474321T3 (da) Sammensætninger til behandling af collagenmedierede sygdomme
DK3456707T3 (da) 4-(p-quinonyl)-2-hydroxybutanamidderivater til behandling af mitokondriesygdomme
EP2132133A4 (en) RELEASE OF PARTICULATE ACTIVE SUBSTANCES
DK2462116T3 (da) Fremgangsmåde til fremstillingen af farmaceutisk aktive forbindelser
DK2222272T3 (da) Behandling af luftvejssygdom
DK2285808T3 (da) Spiroindolderivater til behandling af parasitsygdomme
DK2073860T3 (da) Lægemiddelfrigivende coatinger til medicinske indretninger
DK2056842T3 (da) Modificeret galactosylceramid til behandling af cancerøse sygdomme
DK1874781T3 (da) Dihydrothienopyrimidiner til behandling af inflammatoriske sygdomme
HUE054495T2 (hu) Rák kezelésére szolgáló készítmény
DK2440230T3 (da) Behandlingsregimener til behandling af neurologisk sygdom
PL2464342T3 (pl) Formulacje farmaceutyczne do zapobiegania niewłaściwemu użyciu leków medycznych
DK2114386T3 (da) Farmaceutisk sammensætning til behandling af diabeteskomplikationer
DK2627345T3 (da) Formuleringer til behandling af sygdomme i de øvre luftveje
DK2506712T3 (da) Morfinanderivater til behandling af lægemiddeloverdosering
DK2451482T3 (da) Kombinationsterapi til behandlingen af diabetes
DK2236149T3 (da) Medicinsk sammensætning til behandling af respiratoriske infektions-sygdomme
PL2582366T3 (pl) Kombinacja farmaceutyczna do leczenia bólu
BRPI0815551A2 (pt) Tratamento através de hucbc de doença beta-amiloide
DK2117565T3 (da) Anvendelse af chitosaner til behandlingen af negleinflammatoriske sygdomme
GB0906159D0 (en) Drug combination for the treatment of proteostatic diseases